에 대한 최신 뉴스 Kimberly-Clark (NYSE:KMB) 주식

Kimberly-Clark

With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Equities

News

Previews

Tech

Trading Ideas

ABBV

AGYS

ASML

BJRI

CHKP

CHTR

CMCSA

DECK

GATX

GOOG

GOOGL

JNPR

NFLX

NXPI

ODFL

ORLY

SKYW

SPOT

TSLA

VRSN

S&amp;P 500 기업들 중 약 14%가 6월 분기 실적을 발표했으며, 더 넓은 지수를 구성하는 기업들의 혼합 실적 성장률은 여전히 ​​양호하다. 이번 주에는 기술 보고 시즌이 공식적으로 시작될 것이며, 이는 최근 주에 가파른 하락세를 보인 시장의 향방을 잠재적으로 결정할 수 있다.

테슬라, 알파벳, GM 및 포드가 이번 주 실적 발표 주도하며 상승세 유지 위해 고군분투

Kimberly-Clark Corp

KAMBI GROUP LTD ORD B by Kambi Group LTD.

Kambi Group PLC

Analyst Ratings

ADBE

MDLZ

SNOW

WYNN

Live On CNBC, Brenda Vingiello Announces Sold Advanced Micro Devices; Trimmed Adobe Position; Sold Mondelez International; Bought More Wynn Resorts; Bought Snowflake; Bought Kimberly-Clark

Barclays analyst Lauren Lieberman maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Equal-Weight and lowers the price target from $144 to $132.

Price Target

Barclays Maintains Equal-Weight on Kimberly-Clark, Lowers Price Target to $132

UBS analyst Peter Grom maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Neutral and lowers the price target from $151 to $132.

UBS Maintains Neutral on Kimberly-Clark, Lowers Price Target to $132

JP Morgan analyst Andrea Teixeira maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Underweight and lowers the price target from $140 to $124.

JP Morgan Maintains Underweight on Kimberly-Clark, Lowers Price Target to $124

Citigroup analyst Filippo Falorni maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Sell and lowers the price target from $125 to $118.

Citigroup Maintains Sell on Kimberly-Clark, Lowers Price Target to $118

TD Cowen analyst Robert Moskow downgrades Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) from Buy to Hold and announces $145 price target.

Downgrades

TD Cowen Downgrades Kimberly-Clark to Hold, Announces $145 Price Target

During the last three months, 7 analysts shared their evaluations of Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>), revealing diverse outlooks from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $147.57, a high estimate of $165.00, and a low estimate of $130.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.34%. 
<img src="https://www.benzinga.com/files/images/story/2025/1736280035_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A clear picture of Kimberly-Clark's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$130.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$161.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$140.00</td>
<td>$142.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$151.00</td>
<td>$153.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$144.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$142.00</td>
<td>$137.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Kimberly-Clark. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Kimberly-Clark compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Kimberly-Clark's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Kimberly-Clark's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/KMB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Kimberly-Clark analyst ratings.</a>
<h2>Unveiling the Story Behind Kimberly-Clark</h2>
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
<h3>Key Indicators: Kimberly-Clark's Financial Health</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Kimberly-Clark's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -3.51% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 18.32%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Kimberly-Clark's ROE stands out, surpassing industry averages. With an impressive ROE of 74.93%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Kimberly-Clark's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.27% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Kimberly-Clark's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 5.8.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Kimberly-Clark: Insights From 7 Financial Analysts

Wells Fargo analyst Chris Carey maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Equal-Weight and lowers the price target from $140 to $130.

Wells Fargo Maintains Equal-Weight on Kimberly-Clark, Lowers Price Target to $130

Piper Sandler analyst Korinne Wolfmeyer maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Overweight and lowers the price target from $175 to $161.

Piper Sandler Maintains Overweight on Kimberly-Clark, Lowers Price Target to $161

Over the next three years, the GDTC plans to continue its expansion, focusing on advancing AI/ML capabilities and developing innovative digital solutions to boost operational efficiency and customer engagement.&nbsp;

Kimberly-Clark Increases Its Commitment To India Through Its Global Digital Technology Center In Bengaluru

Costco Wholesale Corp. is switching manufacturers for its popular Kirkland Signature brand of diapers as its supplier moves away from store brands to boost profitability.&nbsp;
&nbsp;
<a href="https://www.bloomberg.com/news/articles/2024-12-09/costco-s-cost-popular-kirkland-baby-diapers-are-getting-a-new-supplier?embedded-checkout=true" title="https://www.bloomberg.com/news/articles/2024-12-09/costco-s-cost-popular-kirkland-baby-diapers-are-getting-a-new-supplier?embedded-checkout=true">https://www.bloomberg.com/news/articles/2024-12-09/costco-s-cost-popular-kirkland-baby-diapers-are-getting-a-new-supplier?embedded-checkout=true</a>

COST

'Costco's Popular Kirkland Baby Diapers Are Shifting Suppliers' - Bloomberg

RBC Capital analyst Nik Modi reiterates Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Outperform and maintains $165 price target.

Reiteration

RBC Capital Reiterates Outperform on Kimberly-Clark, Maintains $165 Price Target

JP Morgan analyst Andrea Teixeira maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Underweight and lowers the price target from $142 to $140.

JP Morgan Maintains Underweight on Kimberly-Clark, Lowers Price Target to $140

UBS analyst Peter Grom maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Neutral and lowers the price target from $153 to $151.

UBS Maintains Neutral on Kimberly-Clark, Lowers Price Target to $151

Goldman Sachs analyst Bonnie Herzog reiterated the Buy rating on Kimberly-Clark Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) stock, <a target="_blank" href="https://www.benzinga.com/quote/KMB/analyst-ratings" rel="noreferrer noopener">with a price forecast of $152.</a>
The company reported third quarter adjusted earnings per share of $1.83, beating the street view of $1.70. Quarterly revenues of $4.952 billion<a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41446271/kimberly-clark-announces-third-quarter-2024-results-and-reaffirms-2024-profit-outlook" rel="noreferrer noopener"> missed the analyst consensus of $5.048 billion.</a>
According to Herzog, Kimberly-Clark&#8217;s management efforts on productivity and the current environment are conducive to margin expansion.
The analyst projects that the market underestimates the company&#8217;s potential for gross margin growth, which should lead to healthy EPS growth despite increased reinvestments.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41453793/retail-inventory-pressures-hit-kimberly-clarks-annual-outlook-stock-slides" rel="noreferrer noopener">Retail Inventory Pressures Hit Kimberly-Clark&#8217;s Annual Outlook, Stock Slides</a>
Herzog also forecasts that Kimberly-Clark&#8217;s segment reorganization will enhance execution moving forward.
As a result, the analyst sees a favorable risk/reward scenario, with Kimberly-Clark&#8217;s improving fundamentals contrasting sharply with its deep valuation discount compared to its HPC peers, offering an attractive entry point for investors.
The analyst indicated that adjusted EBIT is expected to grow in the mid-to-high teens on a constant currency basis, with adjusted EPS also projected to rise similarly.
For the fourth quarter of 2024, organic sales growth is expected to be about 4% at the mid-point, versus Goldman Sachs&#8217; estimate of 5.0%.
The projected all-in EPS is $1.46, ranging from $1.33 to $1.60, reflecting a constant currency growth of 15% &#8211; 19%, compared to Goldman Sachs&#8217; estimate of $1.60.
Price Action: KMB shares are trading lower by 4.30% to $138.01 at last check Tuesday.
Photo via Shutterstock
Read Also:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41375637/market-very-convinced-of-a-trump-win-says-stanley-druckenmiller-why-billionaire-inv" target="_blank" rel="noreferrer noopener">Market &#8216;Very Convinced&#8217; Of A Trump Win, Says Stanley Druckenmiller: Why Billionaire Investor Thinks Blue Sweep Is &#8216;Highly Unlikely&#8217;</a></li>
</ul>

Analyst Color

Markets

General

Kimberly-Clark's Growth Potential 'Underestimated,' Analyst Sees Attractive Entry Point

Wall Street traded lower for the second consecutive day on Tuesday, as investor sentiment turned cautious with the U.S. presidential election <a href="https://www.benzinga.com/topic/2024-elections">just two weeks away. </a>
Concerns over U.S. fiscal policies and potential shifts in economic direction fueled the pause in risk-taking.
The International Monetary Fund (IMF) upgraded its U.S. growth forecasts for 2024 and 2025 in the latest World Economic Outlook, while also flagging rising concerns about the country's debt trajectory, warning that with current large fiscal deficits, &#8220;the U.S. public debt is not stabilized.&#8221;
Commodities were the standout performers on Tuesday, with both metals and energy experiencing notable gains.
Gold, tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), rose 0.8%, pushing further into record territory. This increase extended its year-to-date performance to 34%, positioning gold for its strongest <a href="https://www.benzinga.com/markets/bonds/24/10/41455678/gold-on-track-for-best-year-since-1979-veteran-investor-says-sell-bonds-buy-gold">annual gain since 1979.</a> Gold miners, as represented by the VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>), rallied for the ninth consecutive session, hitting their highest levels in over four years.
Silver, tracked by the iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>), surged 2.8%, reaching levels not seen since October 2012.
Oil prices rallied nearly 3%, building on a 2% surge from Monday. U.S. Treasury yields ticked up modestly on Tuesday following Monday's spike, with the 10-year yield settling at 4.21%.
Meanwhile, the U.S. Dollar Index (DXY), tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), climbed past the 104 mark, continuing its steady ascent and eyeing a fourth consecutive week of gains.
In the cryptocurrency market, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell 0.5%, dipping to around $67,000 and marking its second consecutive day of declines.
<h3 class="wp-block-heading">Tuesday&#8217;s Performance In US Major Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %change</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,907.57</td>
<td>-0.1 %</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,840.39</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,291.15</td>
<td>-0.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,228.60</td>
<td>-0.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:35 p.m. ET</figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent102224&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.3% to $581.79.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.1% lower to $429.14.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.4% to $493.29.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.5% $221.04.</li>
<li>The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 0.6%. The Industrial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>) lagged, down 1.1%.</li>
</ul>
<h3 class="wp-block-heading">Tuesday&#8217;s Stock Performers</h3>
General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) surged 9%, on track for its strongest session in nearly a year, after reporting stronger-than-expected earnings and announcing an additional $5 billion share buyback program extending into next year.
Other stocks reacting to earnings include: 
<ul>
<li>Southern Copper Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCCO#NYSE">SCCO</a>), up 1.5%</li>
<li>Nucor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>), down 6%</li>
<li>W.R. Berkley Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>), down 4.6%</li>
<li>Zion Bancorp. N.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>), up 6.8%</li>
<li>Wintrust Financial Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTFC#NASDAQ">WTFC</a>), up 1.6%</li>
<li>Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>), up 8.8%</li>
<li>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), down over 8%</li>
<li>Danaher Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), down 3%</li>
<li>Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>), down 4.4%</li>
<li>RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>), down 0.4%</li>
<li>Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), down 5.8%</li>
<li>Fiserv Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>), down 0.4%</li>
<li>Moodys Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>) down 4.5%</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), down 0.9%</li>
<li>Freeport-McMoran Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>), up 1.4%</li>
<li>Kimberly-Clark Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>), down 4%</li>
<li>PulteGroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>), down 5.7%</li>
</ul>
Large-cap companies reporting earnings after the close include Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), Baker Hughes Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>), Seagate Technology Holdings PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>), Packaging Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>), Manhattan Associates Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>), East West Bancorp. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) and Enphase Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>)
Now Read:
<ul>
<li><a href="https://www.benzinga.com/government/24/10/41455013/how-us-elections-could-impact-us-dollar-goldman-sachs-expects-greenback-will-remain-stronger-for-lon">How US Elections Could Impact US Dollar: Goldman Sachs Expects Greenback Will Remain &#8216;Stronger For Longer&#8217;</a></li>
</ul>
Image: Shutterstock

Earnings

Large Cap

Mid Cap

Sector ETFs

Broad U.S. Equity ETFs

New ETFs

Commodities

Currency ETFs

Small Cap

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

ENPH

EWBC

Market Vectors ETF Trust Market Vectors Gold Miners

MANH

SCCO

PowerShares DB US Dollar Index Bullish Fund

WTFC

ZION

Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What's Driving Markets Tuesday?

WIIM

Kimberly-Clark shares are trading lower after the company reported worse-than-expected Q3 revenue results and cut its FY24 organic net sales guidance, citing headwinds from changes in retail inventory levels.

Kimberly-Clark Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) shares are<a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener"> trading lower on Tuesday.</a>
The company reported third quarter adjusted earnings per share of $1.83, beating the street view of $1.70. Quarterly revenues of $4.952 billion<a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41446271/kimberly-clark-announces-third-quarter-2024-results-and-reaffirms-2024-profit-outlook" rel="noreferrer noopener"> missed the analyst consensus of $5.048 billion.</a>
Quarterly sales were down 4%, with organic sales growth of 1% versus the prior year.
Kimberly-Clark&#8217;s quarterly adjusted gross margin was 36.7%, up 90 basis points versus the prior year, driven by strong gross productivity gains.
The company&#8217;s volume and mix were positive in Developed Markets (representing&nbsp;Australia,&nbsp;South Korea, and Western/Central Europe), offset by a decline in&nbsp;North America,&nbsp;while volumes in Developing and Emerging (D&amp;E) markets were in line with the year-ago period.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41447996/us-stocks-remains-on-edge-ahead-of-flurry-of-earnings-from-lockheed-martin-gm-and-others-this-is-st" rel="noreferrer noopener">US Stocks Remains On Edge Ahead Of Flurry Of Earnings From Lockheed Martin, GM And Others: This Is Still A &#8216;Buy The Dip&#8217; Market, Says Expert</a>
Quarterly adjusted operating profit increased by 5% despite an unfavorable impact of 4 percentage points from currency translation that was primarily driven by hyperinflationary economies.
Excluding currency impacts, growth in adjusted operating profit reflected gross productivity gains, relatively neutral&nbsp;pricing net of cost inflation, supply chain related investments, as well as planned increases in marketing, research and general expenses.
Personal Care sales were $2.6 billion, down 2%, but organic sales in the segment grew 3% due to pricing actions in inflationary markets and better product mix, with volume steady across all markets.
Consumer Tissue sales were $1.5 billion, also down 2%, with segmental organic sales declining by 1%.
KCP sales fell 10% to $767 million due to divestitures and unfavorable currency effects.
The company exited the quarter with cash and equivalents worth $1.11 billion. Inventories as of quarter-end was $1.937 billion.
FY24 Outlook: The company expects organic net sales to grow by 3%-4%, down from a mid-single-digit rate, mainly due to changes in retail inventory levels. Reported net sales will still be negatively affected by 400 basis points from currency translation and 120 basis points from divestitures.
Adjusted operating profit and adjusted earnings per share are expected to grow at a mid-to-high teens percentage rate in constant currency.
Reported operating profit and reported earnings per share are now projected to be negatively impacted by about 650 basis points from currency translation, an improvement from the previous expectation of 700 basis points.
Price Action: KMB shares are trading lower by 5.12% to $136.83 premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41445510/tesla-shareholders-demand-answers-from-elon-musk-on-growing-list-of-promises-ahead-of-q3-earning" target="_blank" rel="noreferrer noopener">Tesla Shareholders Demand Answers From Elon Musk On Growing List Of Promises Ahead Of Q3 Earnings: From Affordable Models To FSD Rollout And Next-Generation Roadster</a></li>
</ul>

Guidance

Movers

Retail Inventory Pressures Hit Kimberly-Clark's Annual Outlook, Stock Slides

Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) reported quarterly earnings of $1.83 per share which beat the analyst consensus estimate of $1.70 by 7.65 percent. This is a 5.17 percent increase over earnings of $1.74 per share from the same period last year. The company reported quarterly sales of $4.952 billion which missed the analyst consensus estimate of $5.048 billion by 1.89 percent. This is a 3.51 percent decrease over sales of $5.132 billion the same period last year.

Earnings Beats

Earnings Misses

CORRECTION: Kimberly-Clark Q3 2024 Adj. EPS $1.83 Beats $1.70 Estimate, Sales $4.952B Miss $5.048B Estimate

Kimberly-Clark Says Reported Operating Profit And EPS Are Now Expected To Be Negatively Impacted By Approximately 650 Basis Points From Currency Translation Versus A Previous Expectation Of 700 Basis Points

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President-...

Trump Trade: President-elect prepares executive orders to boost fossil fuels

UBS lowered the firm's price target on Kimberly-Clark (KMB) to $132 from $151 and keeps a Neutral rating on the shares. Sentiment around Consumer S...

Kimberly-Clark price target lowered to $132 from $151 at UBS

General optimism for the U.S. economy has been disrupted by uncertainty surrounding policy changes, geopolitical tensions, and border crises. Amid this volatility, investing in sound consumer staple stocks Colgate-Palmolive (CL), Chewy (CHWY), and Kimberly-Clark (KMB) could offer investors a reliable path to steady returns. Read more… With President-elect Donald Trump's second term beginning in less than two weeks, the U.S. economy has yet to fend off market uncertainties positively. Geopolitical crises, incoming policy changes, and an existing border crisis have turned up the volatility knob, leading to an uncertain market.
Amid this, consumer staples remain a stable investment option, acting as a buffer against these uncertainties. Thus, investors could scoop up shares of fundamentally stable consumer staple stocks Colgate-Palmolive Company (<a href="https://stocknews.com/stock/CL/">CL</a>), Chewy, Inc. (<a href="https://stocknews.com/stock/CHWY/">CHWY</a>), and Kimberly-Clark Corporation (<a href="https://stocknews.com/stock/KMB/">KMB</a>) to look for steady returns in these uncertain times.
With his proposed <a href="https://abcnews.go.com/Business/trumps-proposed-tariffs-raise-prices-products-experts/story?id=115893557">60% tariffs on Chinese goods</a> and a pledged 25% tariff on Canadian imports within his initial days in office, Trump's statements on trade policies have not been perceived as the most welcoming message to world leaders. Corporations, no matter how big or small, are expected to take a hit due to these tariff changes.
On the other hand, Trump's stance on <a href="https://www.brookings.edu/articles/how-is-trumps-reelection-likely-to-affect-us-foreign-policy/">the U.S.-Mexico border crisis</a> threatens to deepen challenges between the two nations. This means a threat to both the Mexican and American economies as interchanged goods and services between these two nations are to face significant red tape going forward.
Additionally, Trump's vows to end the Ukraine-Russia war, the ongoing altercation in the Middle East, as well as his ‘joking' statement to include <a href="https://www.forbes.com/sites/mollybohannon/2025/01/06/trump-says-canada-should-merge-with-us-trolling-trudeau-as-he-steps-down/">Canada as the 51st U.S. State</a> have all contributed to the mix of political and global uncertainty. Furthermore, hints of wanting the Panama Canal and Greenland under American control or ownership have also been observed.
Amid this concerning politically uncertain times, consumer staples remain a stable investment option. These products maintain the principle of <a href="https://www.investopedia.com/terms/e/inelastic.asp">inelastic demand</a>, holding their needs and demand even if costs climb.
So now, let us dive deep into the fundamentals of three <a href="https://stocknews.com/category/consumer-goods/">Consumer Goods</a> stocks, starting with #3.
Stock #3: Colgate-Palmolive Company (<a href="https://stocknews.com/stock/CL/">CL</a>)
CL manufactures and sells consumer products. The company has two segments: Oral, Personal and Home Care; and Pet Nutrition. It sells its products under various brands such as Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, and more.
CL's trailing-12-month <a href="https://www.investopedia.com/terms/g/gross_profit_margin.asp">gross profit margin</a> of 60.42% is 66.4% higher than the industry average of 36.32%. Its trailing-12-month levered FCF margin of 14.82% is 161.6% higher than the sector average of 5.66%. Furthermore, the stock's trailing-12-month net income margin of 14.26% is 232.3% higher than the 4.29% industry average.
For the fiscal 2024 third quarter that ended September 30, CL's net sales increased 2.4% year-over-year to $5.03 billion. Its non-GAAP operating profit increased 4.8% year-over-year to $1.08 billion.
Additionally, non-GAAP net income attributable to CL and non-GAAP EPS grew 5.6% and 5.8% from the prior year's quarter to $750 million and $0.91, respectively.
Analysts expect CL's revenue and EPS for the fiscal 2024 fourth quarter (ended December 2024) to increase 1.7% and 3.2% year-over-year to $5.04 billion and $0.90, respectively. Additionally, the company topped the consensus revenue and EPS estimates in all four trailing quarters, which is noteworthy.
CL's shares have surged 9.3% over the past year to close the last trading session at $87.39.
CL's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect its fundamentals. The stock has an A grade for Quality and a B for Stability. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.
Within the <a href="https://stocknews.com/category/consumer-goods/">Consumer Goods</a> industry, CL is ranked #18 out of 54 stocks. In addition to the POWR Rating highlighted above, you can check CL's ratings for Growth, Momentum, Sentiment, and Value <a href="https://stocknews.com/stock/CL/">here</a>.
Stock #2: Chewy, Inc. (<a href="https://stocknews.com/stock/CHWY/">CHWY</a>)
CHWY is a dedicated e-commerce platform specializing in pet care. It provides a comprehensive range of products and services, including pet food, treats, supplies, medications, and services for a variety of pets, dogs, cats, fish, birds, small animals, horses, and reptiles, accessible through its retail websites and mobile apps.
CHWY's trailing-12-month ROCE of 130.34% is significantly higher than the industry average of 10.88%. Its trailing-12-month ROTC of 7.31% is 17.4% higher than the sector average of 6.22%. Likewise, the stock's trailing-12-month asset turnover ratio of 3.88x is 295% higher than the industry average of 0.98x.
For the fiscal 2025 third quarter that ended October 27, 2024, CHWY's net sales increased 4.8% year-over-year to $2.88 billion. Its income from operations amounted to $25.63 million, compared to a loss from operations of $9.72 million the previous year's quarter.
Moreover, adjusted net income and adjusted EPS attributable to common Class A and Class B stockholders grew 33.8% and 33.3% from the year-ago value to $84.92 million and $0.20, respectively.
Street expects CHWY's revenue and EPS for the fiscal 2025 fourth (quarter ending January 2025) to increase 12.9% and 10.4% year-over-year to $3.19 billion and $0.20, respectively. Moreover, the company topped the consensus revenue estimates in all four trailing quarters, which is noteworthy.
Shares of CHWY have surged 43.2% over the past six months and 75.1% over the past year, closing the last trading session at $35.77.
CHWY's sound fundamentals are mirrored in its POWR Ratings. The stock has an overall rating of B, translating to a Buy in our proprietary rating system.
CHWY has a B grade for Quality. Within the Consumer Goods industry, it is ranked #13 out of 54 stocks.
To access CHWY's Growth, Stability, Value, Momentum, and Sentiment ratings, <a href="https://stocknews.com/stock/CHWY/">click here</a>.
Stock #1: Kimberly-Clark Corporation (<a href="https://stocknews.com/stock/KMB/">KMB</a>)
KMB manufactures and markets personal care and consumer tissue products. The company has three segments: Personal Care; Consumer Tissue; and K-C Professional. It offers products under brands like Huggies, Pull-Ups, Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, and more.
On December 26, 2024, KMB announced <a href="https://investor.kimberly-clark.com/2024-12-26-Indias-Thriving-Tech-Hub-Fuels-Kimberly-Clarks-Digital-Transformation">significant digital transformation</a> through its  Global Digital Technology Center (GDTC) in Bengaluru, India. Established with an initial investment of $2.5 million, this GDTC focuses on key areas and digital capabilities such as Data and Analytics, Artificial Intelligence (AI) including Generative AI, Machine Learning (ML), Cloud Transformation, and more.
The Bengaluru GDTC is set to continue its expansion, focusing on advancing AI/ML capabilities and developing innovative digital solutions to boost operational efficiency and customer engagement, contributing to India's broader tech and innovation ecosystem and enhancing the company's global presence.
KMB's trailing-12-month levered FCF margin of 12.41% is 119.1% higher than the industry average of 5.66%. Its trailing-12-month EBITDA margin of 19.39% is 52% higher than the 12.76% industry average. Additionally, the stock's trailing-12-month net income margin of 12.97% is 202.2% higher than the sector average of 4.29%.
For the fiscal third quarter that ended September 30, 2024, KMB's net sales came in at $4.95 billion. Its operating profit increased 49.1% year-over-year to $1.15 billion.
Additionally, adjusted net income attributable to KMB and adjusted EPS rose 4.6% and 5.2% from the prior year's quarter to $617 million and $1.83, respectively.
The consensus revenue estimate for the fiscal year ending December 2025 amounts to $20 billion. Its EPS for the same period is expected to rise 4.2% year-over-year to $7.63. Furthermore, the company surpassed the consensus EPS estimates in three of four trailing quarters.
Shares of KMB have surged marginally over the past nine months and 4.1% over the past year to close the last trading session at $127.30.
KMB's POWR Ratings reflect its robust prospects. The stock has an overall rating of B, equating to a Buy in our proprietary rating system.
KMB has a B grade for Quality, Value, and Sentiment. It is ranked #5 out of 54 stocks in the Consumer Goods industry.
<a href="https://stocknews.com/stock/KMB/">Click here</a> to access KMB's ratings for Stability, Momentum, and Growth.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
CL shares were unchanged in premarket trading Wednesday. Year-to-date, CL has declined -3.87%, versus a 0.44% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Aritra_Gangopadhyay</h2> <img src='https:/wp-content/uploads/2025/01/Aritra_Gangopadhyay.png' style="float:left; padding:5px;width:125px;">Aritra is a financial journalist dedicated to breaking down complex financial topics into simple, actionable insights. Holding a Master's degree in Economics, he uses his analytical expertise to help investors uncover unique opportunities for long-term success.<a href="https://stocknews.com/authors/?author=aritra-gangopadhyay">More...</a>The post <a href=https://stocknews.com/news/cl-kmb-chwy-3-consumer-staples-stocks-for-steady-returns-in-uncertain-times/>3 Consumer Staples Stocks for Steady Returns in Uncertain Times</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Consumer Staples Stocks for Steady Returns in Uncertain Times

Dividend Aristocrats are a shield during market turbulence and a key to diversified growth. Therefore, investors looking for stability and dependable income might consider adding fundamentally stable stocks Johnson & Johnson (JNJ), PepsiCo (PEP), and Kimberly-Clark (KMB). Continue reading… Dividend Aristocrats are companies with a track record of increasing dividends for 25 consecutive years or more and are often considered a cornerstone of a reliable investment strategy. These stocks belong to stable, well-established companies that can weather economic downturns while rewarding shareholders with consistent payouts.
Amid this backdrop, it could be wise to scoop up shares of dividend aristocrats stocks Johnson &amp; Johnson (<a href="https://stocknews.com/stock/JNJ/">JNJ</a>), PepsiCo, Inc. (<a href="https://stocknews.com/stock/PEP/">PEP</a>), and Kimberly-Clark Corporation (<a href="https://stocknews.com/stock/KMB/">KMB</a>) for their resilience and long-term gains.
In the third quarter of 2024, <a href="https://www.bea.gov/news/2024/gross-domestic-product-third-estimate-corporate-profits-revised-estimate-and-gdp-1">real GDP increased at an annual rate of 3.1%</a> year-over-year. This shift was due to factors like increased consumer spending, exports, federal government spending, and a rise in business investment.
Investors are drawn to Dividend Aristocrats for their ability to provide a stable income stream, which can <a href="https://www.investopedia.com/terms/d/dividend-aristocrat.asp">act as a cushion during volatile market conditions</a>. Further, dividend aristocrats often outperform during bear markets, owing to their defensive nature that helps preserve capital, as many of these companies operate in non-cyclical industries like healthcare, consumer staples, and utilities.
With that in mind, let's delve into the fundamentals of the above-mentioned three Dividend Aristocrat picks.
Johnson &amp; Johnson (<a href="https://stocknews.com/stock/JNJ/">JNJ</a>)
JNJ is engaged in the research and development, manufacture, and sale of healthcare products primarily focused on human health and well-being. The company offers a diversified range of products through the Innovative Medicine segment and MedTech segment.
On January 2, the company declared a quarterly <a href="https://www.investopedia.com/terms/d/dividend.asp">dividend</a> of $1.24 per share, payable on March 4, to shareholders of record on February 18. With 62 years of consecutive dividend growth, JNJ pays an annual dividend of $4.96, which translates to a yield of 3.44% at the current share price. Its four-year average dividend yield is 2.74%. Also, the company's dividend payouts have increased at a CAGR of 5.5% over the past five years.
On December 2, JNJ announced that it received the U.S. Food and Drug Administration (FDA) approval for a first-of-its-kind silicone gel-filled implant, MENTOR&#x2122; MemoryGel&#x2122; Enhance Breast Implants. This launch is the first and only implant line created specifically for women with larger breast cup sizes undergoing breast reconstruction and reconstruction revision and will be commercially available in mid-2025.
For the nine-month period that ended September 30, 2024, JNJ's sales to customers increased 4% year-over-year to $66.30 billion. Its gross profit rose 4.5% from the year-ago value to $45.96 billion. The company's net earnings from continuing operations amounted to $6.84 billion, representing a 15.7% increase from the same period last year. Also, its net earnings per share from continuing operations for the period increased 24.1% year-over-year to $4.38.
As per the updated guidance for the fiscal year 2024, JNJ forecasts operational sales between $89.40 billion and $89.80 billion, reflecting a 6.6% increase from 2023, primarily driven by recent acquisitions. The company also expects adjusted EPS between $9.88 and $9.98.
Street expects JNJ's revenue for the fiscal year (ended December 2024) to increase 4.3% year-over-year to $88.78 billion. Its EPS for the same period is expected to register a marginal growth from the prior year, settling at $9.96.
Shares of JNJ have declined marginally intraday, closing the last trading session at $143.78.
JNJ's strong fundamentals are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of A, which equates to a Strong Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.
JNJ has a B grade for Value, Stability, Sentiment, and Quality. It is ranked #11 out of 152 stocks in the <a href="https://stocknews.com/category/pharmaceuticals/">Medical - Pharmaceuticals</a> industry. <a href="https://stocknews.com/stock/JNJ/">Click here</a> to see the additional ratings for JNJ (Growth and Momentum).
PepsiCo, Inc. (<a href="https://stocknews.com/stock/PEP/">PEP</a>)
PEP is a global beverage and convenience food company that engages in its manufacturing, marketing, distribution, and sales. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region.
On November 22, PEP announced its agreement to acquire the remaining 50% stake in Sabra Dipping Company and Obela. With this acquisition, PEP will become the sole owner of these refrigerated dips and spreads brands. This move should expand PEP's portfolio in the U.S. and Canada, meeting the growing demand for nutritious, simple foods.
In the same month, demonstrating its commitment to returning value to shareholders, the company declared the 52nd consecutive quarterly dividend of $1.355 per common share, a 7% increase year-over-year. This dividend will be paid on January 6, 2025.
PEP pays an annual dividend of $5.42, which translates to a yield of 3.61% at the current share price. Its four-year average dividend yield is 2.76%. Moreover, its dividend payouts have increased at a CAGR of 7.9% over the past three years.
During the third quarter of 2024, which ended on September 7, PEP's net revenues were $23.32 billion. Its total gross profit rose marginally from the year-ago value to $12.92 billion. Its non-GAAP operating profit stood at $4.18 billion, up 3.6% year-over-year, while its non-GAAP net income attributable amounted to $3.19 billion, representing an increase of 2.6% from the last year. Also, the company's non-GAAP EPS for the quarter increased 2.7% year-over-year to $2.31.
The consensus revenue estimate of $27.96 billion for the fiscal fourth quarter (ended December 2024) represents a marginal increase year-over-year. The consensus EPS estimate of $1.95 for the same quarter indicates a 9.4% improvement year-over-year. The company has an excellent earnings surprise history; it surpassed the consensus EPS estimates in each of the trailing four quarters.
The stock has declined marginally intraday to close the last trading session at $149.91.
PEP's bright prospects are reflected in its POWR Ratings. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system.
It also has an A grade for Quality and a B for Growth. Within the B-rated <a href="https://stocknews.com/category/beverages/">Beverages</a> industry, it is ranked #11 out of 32 stocks. <a href="https://stocknews.com/stock/PEP/">Click here</a> to see PEP's ratings for Value, Momentum, Stability, and Sentiment.
Kimberly-Clark Corporation (<a href="https://stocknews.com/stock/KMB/">KMB</a>)
KMB is principally engaged in the manufacturing and marketing of personal care and consumer tissue products in the United States. The company operates through three segments: Personal Care; Consumer Tissue; and K-C Professional.
On January 3, buoyed by strong financial performance, the company paid its shareholders a quarterly dividend of $1.22 per share. KMB pays an annual dividend of $4.88, which translates to a yield of 3.74% at the current share price. Its four-year average dividend yield is 3.52%. Moreover, the company's dividend payouts have increased at a CAGR of 3.4% over the past five years.
KMB's revenue for the third quarter (ended September 30, 2024) amounted to $4.95 billion. It reported an operating profit of $1.15 billion, indicating a 49.1% growth from the prior-year quarter. The company's attributable non-GAAP net income came in at $617 million, and its EPS came in at $1.83 per share, up 4.6% and 5.2% year-over-year, respectively.
Analysts expect KMB's EPS for the fiscal year ended December 2024, 2025, to increase 11.4% year-over-year to $7.32. Its revenue for fiscal 2024 is expected to be $20 billion.
Over the past six months, the stock has surged 6.1%, closing the last trading session at $129.77.
It's no surprise that KMB has an overall rating of B, equating to a Buy in our POWR Ratings system. It has a B grade for Value, Sentiment, and Quality. Out of 55 stocks in the <a href="https://stocknews.com/category/consumer-goods/">Consumer Goods</a> industry, KMB is ranked #5.
Beyond what is stated above, we've also rated KMB for Growth, Momentum, and Stability. Get all KMB ratings <a href="https://stocknews.com/stock/KMB/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
JNJ shares were trading at $144.17 per share on Friday afternoon, up $0.15 (+0.10%). Year-to-date, JNJ has declined -0.31%, versus a 0.93% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: ShreyaRathi</h2> <img src='https:/wp-content/uploads/2024/10/0.jpeg' style="float:left; padding:5px;width:125px;"><a href="https://stocknews.com/authors/?author=shreya-rathi">More...</a>The post <a href=https://stocknews.com/news/jnj-pep-kmb-3-dividend-aristocrats-every-investor-should-own/>3 Dividend Aristocrats Every Investor Should Own</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Dividend Aristocrats Every Investor Should Own

Barclays analyst Lauren Lieberman maintained a Hold rating on Kimberly Clark (KMB – Research Report) today and set a price target of $132.00. The c...

Barclays Reaffirms Their Hold Rating on Kimberly Clark (KMB)

Barclays lowered the firm's price target on Kimberly-Clark (KMB) to $132 from $144 and keeps an Equal Weight rating on the shares as part of a cons...

Kimberly-Clark price target lowered to $132 from $144 at Barclays

RSPS: Consumer Staples Dashboard For January

In a report released on January 15, Nik Modi from RBC Capital maintained a Buy rating on Kimberly Clark (KMB – Research Report), with a price targe...

Kimberly Clark (KMB) Gets a Buy from RBC Capital

AAPL

ANDE

CHWY

DLTR

KVUE

MNST

RSPS

USNA

WFRD

Press Releases

Huggies® Promotes Safe Sleep During Safe Sleep Awareness Month

Kimberly-Clark Announces Third Quarter 2024 Results and Reaffirms 2024 Profit Outlook

U by Kotex® Launches MaxiMalism Jeans to Help End Shame Around Periods

Lauren Brazel of Tinley Park High School Is Named the Grand Prize Winner of the Heroes of the Classroom Program Presented by Kleenex®

Kimberly-Clark Elects Joseph Romanelli to its Board of Directors

Dividends

Kimberly-Clark Declares Quarterly Dividend and Announces Date of 2024 Annual Shareholder Meeting

Kimberly-Clark to Webcast its Presentation at Morgan Stanley's Global Consumer & Retail Conference

KATHERINE HEIGL ADMITS TO A LITTLE "GIGGLE DRIBBLE" IN NEW POISE® CAMPAIGN THAT AIMS TO HELP NORMALIZE WOMEN'S BLADDER LEAKS

India's Thriving Tech Hub Fuels Kimberly-Clark's Digital Transformation

Kimberly-Clark to Announce Fourth Quarter and Full Year 2024 Results on January 28, 2025

Central Garden & Pet Company - Common Stock

Central Garden & Pet

Central Garden & Pet Company - Class A Common Stock Nonvoting

Church & Dwight Company, Inc. Common Stock

Church & Dwight Co

Colgate-Palmolive

Clorox

Energizer Hldgs

Oil-Dri Corporation Of America Common Stock

Oil-Dri Corp of America

Procter & Gamble Company (The) Common Stock

Procter & Gamble

Reynolds Consumer Products Inc. - Common Stock

Reynolds Consumer Prods

Spectrum Brands Holdings, Inc. Common Stock

Spectrum Brands Holdings

WD-40

Barclays

JP Morgan

Citigroup

TD Cowen

S&amp;P 500 기업들 중 약 <a href="https://www.benzinga.com/news/earnings/24/07/39769910/goldman-sachs-q2-earnings-revenue-and-eps-beat-investment-banking-fees-up-21-hikes-dividend" target="_blank" rel="noopener" data-google-interstitial="false">14%가 6월 분기 실적을 발표</a>했으며, 더 넓은 지수를 구성하는 기업들의 혼합 실적 성장률은 여전히 ​​양호하다. 이번 주에는 기술 보고 시즌이 공식적으로 시작될 것이며, 이는 최근 주에 가파른 하락세를 보인 시장의 향방을 잠재적으로 결정할 수 있다.
지난주 주요 사건: 기술주의 실적 시즌은 지난주 칩 장비 제조업체 ASML 홀딩 N.V.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>)의 실적 발표로 와만하게 시작되었다. 이 회사의 주가는 약한 3분기 전망과 중국 칩 금지를 둘러싼 지정학적 우려로 인해 약 16% 하락했다. 넷플릭스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>)의 지침은 투자자들을 실망시켰지만 증권사 측 분석가들이 결과에 열광하면서 주가는 크게 하락하지 않았다.
투자자들은 뱅크 오브 아메리카(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), 모건 스탠리(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) 및 골드만삭스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) 등 나머지 대형 은행들의 실적 보고서에 환호했다. 투자 은행 사업의 반등과 강력한 트레이딩 매출이 은행들의 매출을 강화하는 데 도움이 되었다.
팩트셋(FactSet)의 최신 실적 전망 조사 <a href="https://advantage.factset.com/hubfs/Website/Resources%20Section/Research%20Desk/Earnings%20Insight/EarningsInsight_071924.pdf">보고서</a>에 따르면 이들 기업 중 80%가 예상보다 높은 주당 이익을 보고했는데, 이는 5년 평균인 77%와 비교된다. 평균 상승 여력은 약 5.5%이지만, 이는 5년 평균 상승률 8.6%보다 낮다.
관련 정보: <a href="https://www.benzinga.com/money/best-tech-stocks">지금 가장 핫한 기술주</a>
실적 트렌드: 팩트셋에 따르면 S&amp;P 500 기업들의 2분기 혼합 실적 증가율은 현재 9.7%로 전주의 9.1%보다 높아진 것으로 추정된다. 이 추정치가 달성되면 분기 실제 성장률은 2021년 4분기 이후 보고된 전년 동기 대비 가장 높은 성장률을 기록할 것이라고 덧붙였다. 2분기 역시 4분기 연속 성장을 기록할 것으로 보인다.
S&amp;P 500 11개 부문 중 8개 부문이 전년 동기 대비 실적 성장을 기록할 것으로 예상되며, 그 중 통신 서비스, 의료, IT, 금융 부문 4개 부문이 두 자릿수 실적 성장을 기록할 가능성이 높다. 반면, 소재 업종을 중심으로 3개 업종의 실적 감소가 예상된다.
이번 주의 이슈: 이번 주에는 다우 30 지수 구성요소 7개를 포함해 S&amp;P 500 기업 138개 기업들의 실적 보고서가 나올 것이라고 팩트셋의 보고서가 밝혔다. 이번 주의 실적 발표 목록에는 통신, 자동차, 철강, 칩, 주택 건설, 방위, 항공 및 기술 산업의 기업들이 포함된다.
테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)와 알파벳(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)은 S&amp;P 500과 나스닥 지수에서 높은 비중을 차지하고 있어 주목받는 기업들 중 하나이다. 테슬라는 전년 동기 대비 주당 순이익이 91센트에서 62센트로 급격히 감소할 것으로 예상되는 반면, 매출은 훨씬 완만하게 0.80% 감소한 247억 3천만 달러를 기록했을 수 있다. 이 이익성에 더 큰 영향을 미치는 것은 일론 머스크의 회사가 어려운 수요 환경에서 생산량을 늘리기 위해 의존해 온 가격 인하에서 비롯된다.
<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39810457/as-tesla-stock-bounces-back-fund-manager-says-elon-musk-led-company-offers-good-set">분석가들과 펀드 매니저들은</a> 회사가 해당 분기에 양호한 납품 실적을 보고한 후 낙관적이다. 하반기에도 반전이 있을 것으로 예상된다.
알파벳의 실적은 AI를 활용한 거대 기업들 중 최초로 분기별 실적을 발표하는 기업이기 때문에 중요하며, 이는 나머지 기업들의 실적 속도를 정할 수 있다.
지난주 주요 지수가 사상 최고치에서 후퇴하면서 주식시장이 큰 타격을 입었다. Benzinga Pro 데이터에 따르면 나스닥 100 지수의 성과를 추적하는 지수인 Invesco QQQ Trust(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)는 금요일 0.89% 하락한 475.24달러에 마감했다. 이 ETF는 7월 10일에 도달한 502.96달러의 사상 최고치보다 낮게 거래되고 있다. SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)도 금요일 0.66% 하락한 548.99달러로 마감했다.
이번 주 주목할 만한 실적 발표 기업은 다음과 같다:
월요일
개장 전:
<ul>
<li>버라이즌 커뮤니케이션스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>)</li>
</ul>
장 마감 후:
<ul>
<li>애질리시스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>)</li>
<li>클리블랜드 클리프스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>)</li>
<li>뉴코 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>)</li>
<li>NXP 반도체 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>)</li>
</ul>
화요일
개장 전:
<ul>
<li>코카콜라 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>)</li>
<li>프리포트 맥모란 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>)</li>
<li>GATX 코퍼레이션 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GATX#NYSE">GATX</a>)</li>
<li>GE 에어로스페이스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>)</li>
<li>제너럴 모터스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>)</li>
<li>킴벌리 클라크 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>)</li>
<li>록히드 마틴 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>)</li>
<li>필립 모리스 인터내셔널 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>)</li>
<li>풀트그룹 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>)</li>
<li>퀘스트 다이아그노스틱스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>)</li>
<li>스포티파이 테크놀로지 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>)</li>
<li>UPS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>)</li>
</ul>
장 마감 후:
<ul>
<li>알파벳</li>
<li>캐피털 원 파이낸셜 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>)</li>
<li>처브 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>)</li>
<li>마텔 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>)</li>
<li>패키징 코퍼레이션 오브 아메리카 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>)</li>
<li>씨게이트 테크놀로지 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>)</li>
<li>테슬라</li>
<li>텍사스 인스트루먼트 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>)</li>
<li>비자 .(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>)</li>
</ul>
수요일
개장 전:
<ul>
<li>AT&amp;T (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>)</li>
<li>체크포인트 소프트웨어 테크놀로지스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>)</li>
<li>보스톤 사이언티픽 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>)</li>
<li>CME 그룹 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>)</li>
<li>제너럴 다이내믹스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>)</li>
<li>올드 도미니언 프레이트 라인 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>)</li>
<li>GE 베르노바 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>)</li>
<li>써모 피셔 사이언티픽 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>)</li>
</ul>
장 마감 후:
<ul>
<li>치폴레 멕시칸 그릴 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>)</li>
<li>에드워드 라이프사이언스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>)</li>
<li>포드 자동차 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>)</li>
<li>IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>)</li>
<li>나이트 스위프트 트랜스포테이션 홀딩스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>)</li>
<li>라스베가스 샌즈 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>)</li>
<li>메리티지 홈즈 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTH#NYSE">MTH</a>)</li>
<li>월풀 코퍼레이션 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHR#NYSE">WHR</a>)</li>
<li>서비스나우 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) ORLY</li>
<li>오릴리 오토모티브 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>)</li>
</ul>
목요일
개장 전:
<ul>
<li>애브비 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>)</li>
<li>아메리칸 항공 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>)</li>
<li>아스트라제네카 PLC(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>)</li>
<li>컴캐스트 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>)</li>
<li>다우 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)</li>
<li>해즈브로 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>)</li>
<li>허니웰 인터내셔널 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>)</li>
<li>사노피 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>)</li>
<li>사우스웨스트 항공 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>)</li>
<li>ST마이크로일렉트로닉스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STM#NYSE">STM</a>)</li>
<li>유니언 퍼시픽 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>)</li>
<li>제록스 홀딩스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRX#NASDAQ">XRX</a>)</li>
</ul>
장 마감 후:
<ul>
<li>스카이웨스트 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYW#NASDAQ">SKYW</a>)</li>
<li>주니퍼 네트웍스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNPR#NYSE">JNPR</a>)</li>
<li>데커스 아웃도어 코퍼레이션 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>)</li>
<li>보이드 게이밍 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>)</li>
<li>BJ 레스토랑 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJRI#NASDAQ">BJRI</a>)</li>
<li>베리사인 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>)</li>
</ul>
금요일
개장 전:
<ul>
<li>3M 컴퍼니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>)</li>
<li>반즈 그룹 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/B#NYSE">B</a>)</li>
<li>브리스톨-마이어스 스퀴브 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>)</li>
<li>뉴웰 브랜즈 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>)</li>
<li>콜게이트 파몰리브 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>)</li>
<li>차터 커뮤니케이션즈 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>)</li>
</ul>
차기 기사:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39857569/american-express-q2-earnings-ceo-raises-annual-profit-and-marketing-spend-outlook-after-q2-profit-b">아메리칸 익스프레스, 2분기 실적: CEO의 2분기 순이익 안정화에 대한 전망</a></li>
</ul>
Photo: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Kimberly-Clark

뉴스

에 대한 최신 뉴스 Kimberly-Clark (NYSE:KMB) 주식

일요일, 7월 21, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌